MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 12.75
0.00 (0.00%)
Jun 18, 2026, 2:25 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 825.19 million as of June 18, 2026. Its market cap has increased by 30.10% in one year.
Market Cap
825.19M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.75
Market Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 825.19M, a decrease of -60.95%. That is a compound annual growth rate of -18.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 825.19M | 2.41% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.06B |
| Level Biotechnology | 1.02B |
| GeneReach Biotechnology | 991.34M |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 973.67M |
| Taiwan Advance Bio-Pharmaceutical | 913.50M |
| Meribank Biotech | 910.81M |
| NatureWise Biotech & Medicals | 869.55M |